April 26, 2024

• 

[THE INVESTOR] As of Jan. 24 01:41 P.M., InBody fell 4.42% from yesterday to 22,700 won (US$19.49). It rose 10.88% over the past month. Standard deviation for the one month period stood at 2.6%.

Compared with its industry competitors listed on KOSDAQ, the stock price decline to the lowest among the its peer group's, and its volatility for the one month relatively expanded. 

The monthly return-on-risk, indicating the return on investment with consideration for risk, was -4.7%. Compared with the rest of the KOSDAQ industry, the return-on-risk was lower than the industrial mean of -1.0%.

■ Earnings & Valuation

Earnings report for 3Q (July – Sept.) of 2016
Revenue: 179.9 T   Down 5.4% on-quarter, down 2.2% on-year
Operating income: 46.2 T   Down 11.9% on-quarter, down 19.0% on-year
Net income: 31.1 T   Down 32.7% on-quarter, down 42.6% on-year

Investor Groups (Over the past five trading days)
Institutions 5.63%, Foreigners 24.35%, Individuals 70.01%

*Other investor groups including corporations are considered as “individuals.”

By HeRo (hero@heraldcorp.com)

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.